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(i.e., predominantly a disease of male 
patients) and before the formulation of 
the 2007 American Thoracic Society/
Infectious Diseases Society of America 
pulmonary NTM disease criteria (1).
We were limited in drawing fi rm 
conclusions about why pulmonary 
NTM is more common in urban 
areas because we were not able to 
evaluate patients or regional water 
systems within our study. Persons 
living rurally might be less likely to 
seek medical care and thus have NTM 
diagnosed, which would account for 
the differences in our study. However, 
given the reasonably close proximity 
of western Oregon’s rural regions to 
major medical centers, we believe this 
scenario is unlikely.
Our fi ndings suggest that pul-
monary NTM disease is closely 
associated with urban living. We 
suspect the difference in disease rates 
between urban and rural areas might 
refl ect differences in host exposure 
to these pathogens. Further studies 
should be undertaken to elucidate the 
environmental exposures associated 
with pulmonary NTM.
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To the Editor: Neisseria 
meningitidis causes septicemia and 
meningitis (1). Meningococci usually 
persist on the nasopharyngeal mucosa 
of asymptomatic carriers (2). Because 
carriers are the only reservoir of 
meningococci, carriage in at-risk 
populations should be monitored. 
Meningococcal carriage rates have 
been assessed during 1997–8 for 
fi rst-year students at the University 
of Nottingham (3) and in autumn 
during 1999–2001 for >48,000 sixth-
form students (pre-university, age 
range 15–17 years) throughout the 
United Kingdom (4). Serogroup B and 
nongroupable strains predominated; 
serogroup Y strains were found in 
only 1%–2% of participants. 
From November 2008 through 
May 2009, to investigate persistence 
and spread of meningococcal strains 
in students living in dormitories, we 
conducted a longitudinal study in a 
cohort of 190 fi rst-year students at the 
University of Nottingham. We found 
high rates of carriage and prevalence 
of serogroup Y strains (5). 
During September 2009 (fi rst 
week of term) through March 2010, 
we conducted a large repeated cross-
sectional study analyzing pharyngeal 
swabs from students in all school-
year groups at Nottingham University. 
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The objective of this study was 
to determine the signifi cance of 
changes in overall meningococcal and 
serogroup Y-specifi c carriage rates 
among students. 
In September, fi rst-year students 
were recruited on the main campus 
during registration and subsequently 
in dormitories and the main library. 
Undergraduates not in the fi rst year 
were all recruited in the main library. 
This September sample of 823 fi rst-
year students represents 16.5% of 
the 5,000 undergraduate students 
registered each academic year on the 
main campus. Although not intentional, 
some overlap occurred when students 
were resampled during subsequent 
visits to the same dormitories and 
library, e.g., among the 557 fi rst-year 
students from whom swab samples 
were collected in December, 74 
(13%) had previously provided swab 
samples. Our study was approved by 
the Nottingham University Medical 
School Ethics Committee, and written 
informed consent was obtained from 
all participants.
Pharyngeal swab samples were 
spread onto GC selective agar (Oxoid, 
Basingstoke, UK) and incubated at 
37°C in air containing 5% CO2.  After 48 
hours, colonies suggestive of Neisseria 
spp. were examined for positive 
oxidase reaction; single colonies 
were confi rmed as meningococci by 
amplifi cation of meningococcal genes 
crgA plus ctrA and/or porA (6). PCR-
based serogrouping was performed 
as described (6,7). Chi-square tests 
for signifi cance were performed by 
using STATCALC (Epi Info version 
6.04; Centers for Disease Control and 
Prevention, Atlanta, GA, USA).
Among fi rst-year students, 
carriage rates increased from 23.2% 
in late September to 55.7% by mid-
December and remained at a similar 
level in March (Table). Among second- 
and third-year students, carriage rates 
were 34.2% and 30.5% in September, 
respectively, and remained at similar 
levels throughout the academic year. 
The increase in carriage among fi rst-
year students from September through 
December was mainly the result of a 
signifi cant (23%) increase in carriage 
of serogroup Y strains (Table). In 
contrast, during the same period, 
carriage rates of serogroup Y strains 
did not change signifi cantly among 
second- and third-year students 
(Table).
Initial carriage rates were 
signifi cantly higher for incoming 
(fi rst-year) students in September 
2009 than in 1997 (13.9% [3]; χ2 
= 14, 1 df; p<0.0001); swabbing 
and culture protocols and sampling 
sites were identical in both studies, 
so the increases are real. Because 
83% of students at Nottingham 
University come from all regions of 
the United Kingdom and 17% from 
other countries, the increased rates 
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rate, no. (%) 
carriers 
Serogroup distribution 
























109 (57.1) 13.2  
(10.9–15.6) 
 Second, n = 441 151 (34.2)† 34 (22.5) 7.7
(5.2–10.2) 
46 (30.5) 10.4  
(7.6–13.3)§
71 (47.0) 16.1  
(12.7–19.5) 




43 (43.9) 13.4  
(9.7–17.1) 
December 2009 
 First, n = 557 310 (55.7)# 53 (17.1) 9.5
(7.1–12.0) 
142 (45.8) 25.5  
(21.9–29.1)‡ 
115 (37.1) 20.6  
(17.3–24.0) 
 Second, n = 312 123 (39.4)# 33 (26.8) 10.6  
(7.2–14.0) 
32 (26.0) 10.3   
(6.9–13.6)§ 
58 (47.2) 18.6  
(14.3–22.9) 




29 (55.8) 16.1  
(10.7–21.5) 
March 2010 
 First, n = 379 224 (59.1)# 44 (19.6) 11.6  
(8.4–14.9) 




 Second, n = 187 69 (36.9)# 17 (24.6) 9.1
(5.0–13.2) 
25 (36.2) 13.4  
(8.5–18.3)§ 
27 (39.1) 14.4  
(9.4–19.5) 




19 (51.4) 17.0  
(10.1–23.9) 
*CI, confidence interval. 
†Carriage rate significantly lower for first-year students than for other year-group students, p<7  10–2.
‡First-year students, p<8  10–7.
§Second-year students, not significant. 
¶Third-year students, not significant. 
#Carriage rate significantly higher for first-year students than for other year-group students in December 2009 and March 2010, p<10–8.
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of carriage may refl ect a nationwide 
change (8).
Furthermore, testing within the 
fi rst week of term meant that recovered 
strains were predominately brought 
into the university. Serogroup Y 
carriage rates for incoming students 
(2.9%) were signifi cantly higher than 
rates detected by identical genotyping 
methods during 1999–2001 (1.7%–
1.8% [4]; χ2 = 4.6%–6.4%, 1 df; 
p<0.05), suggesting that meningococcal 
carriage by young adults, particularly 
of serogroup Y strains, has increased 
across the United Kingdom. The major 
increase in serogroup Y strains among 
fi rst-year students during 2009–10 
probably resulted from spread of clones 
within dormitories, as observed in the 
2008–9 study (5) and may be facilitated 
by characteristics of the organism, lack 
of immunity, or a combination of these 
factors.
The high prevalence of serogroup 
Y strains in carriers may help explain 
the recent increased incidence of 
serogroup Y disease in the United 
Kingdom: from 20 to 62 laboratory-
confi rmed cases in England and Wales 
from 2003 through 2009 (9). In the 
United States during the late 1990s, 
a similar increase in serogroup Y 
carriage was linked to a concomitant 
increase in serogroup Y disease (10).
In conclusion, in a representative 
UK student cohort we detected 
high rates of carriage and elevated 
prevalence of serogroup Y strains of 
meningococci. Any further signifi cant 
increase in serogroup Y disease should 
lead to prompt reconsideration of the 
current vaccine policy in the United 
Kingdom.
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Pandemic (H1N1) 
2009 in Neonates, 
Japan
To the Editor: In 2009 in Japan, 
a medical response to pandemic 
(H1N1) 2009 infection in neonates was 
proposed by the Japan Pediatric Society 
(JPS) (1). Few such cases have been 
reported (2–7). Because the effects of 
pandemic (H1N1) 2009 in neonates 
are unknown, the JPS Committee 
of Neonatal Medicine conducted 
a nationwide survey during 2009. 
Surveys were mailed to neonatal care 
units in 522 facilities certifi ed by JPS 
as teaching hospitals, which included 
almost all tertiary neonatal intensive 
care units in Japan. The survey asked 
whether during April 2009–March 
2010 any neonates had been born to 
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